The use of regional coordinating centers in large clinical trials: the DIG trial

被引:9
|
作者
Collins, JE
Martin, S
Kent, E
Liuni, C
Garg, R
Egan, D
机构
[1] Cooperat Studies Program Coordinating Ctr, VA Maryland Hlth Care Syst, Dept Vet Affairs, Perry Point, MD 21902 USA
[2] Univ Maryland, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
[3] Univ Alberta, Edmonton, AB, Canada
[4] St Josephs Hosp, Hamilton, ON, Canada
[5] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
[7] NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA
来源
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷 / 06期
关键词
randomized clinical trials; large simple trial; heart failure; digoxin; regional coordinating centers;
D O I
10.1016/S0197-2456(03)00101-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The Digitalis Investigation Group (DIG) trial was a large simple clinical trial that involved 302 participating centers in the United States and Canada. In order to encourage participation by Canadian investigators, to provide additional help to what were expected to be largely research-inexperienced investigators in Canada, and to provide the study's data coordinating center with resources in Canada to deal with potentially different rules, regulations, and cultural differences, regional coordinating centers were established in four regions of Canada: the maritime provinces, Quebec, Ontario, and western Canada. Canadian centers recruited significantly better than their U.S. counterparts and had slightly better retention and follow-up. While it is not possible to declare that the regional coordinating centers were responsible for this improvement, it is believed that these regional centers did play a role. This role included being able to identify investigators who could be expected to do well, providing one-on-one training and instruction to investigators, and being able to solve problems and implement change in the relatively fewer centers in their regions. The regional coordinating center also reduced the intensity of the workload on the data coordinating center by serving as the primary point of contact for Canadian investigators. The use of regional coordinating centers in studies with a large number of participating centers is highly recommended. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:298S / 305S
页数:8
相关论文
共 50 条
  • [41] Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials
    Bhatia, Kirtipal
    Sabharwal, Basera
    Gupta, Kartik
    Lopez, Persio D.
    Kaur, Arpanjeet
    Bhatia, Harsimran K.
    Gandhi, Kruti Dhaval
    Niroula, Shailesh
    Correa, Ashish
    Birati, Edo Y.
    Argulian, Edgar
    Fox, Arieh
    Mahmood, Kiran
    JOURNAL OF CARDIOLOGY, 2024, 83 (02) : 105 - 112
  • [42] Effect of individualized communication skills training on physicians' discussion of clinical trials in oncology: results from a randomized controlled trial
    Wuensch, Alexander
    Goelz, Tanja
    Ihorst, Gabriele
    Terris, Darcey D.
    Bertz, Hartmut
    Bengel, Juergen
    Wirsching, Michael
    Fritzsche, Kurt
    BMC CANCER, 2017, 17
  • [43] Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
    Anker, Stefan D. t
    Schroeder, Stefan
    Atar, Dan
    Bax, Jeroen J.
    Ceconi, Claudio
    Cowie, Martin R.
    AdamCrisp
    Dominjon, Fabienne
    Ford, Ian
    Ghofrani, Hossein-Ardeschir
    Gropper, Savion
    Hindricks, Gerhard
    Hlatky, Mark A.
    Holcomb, Richard
    Honarpour, Narimon
    Jukema, J. Wouter
    Kim, Albert M.
    Kunz, Michael
    Lefkowitz, Martin
    Le Floch, Chantal
    Landmesser, Ulf
    McDonagh, Theresa A.
    McMurray, John J.
    Merkely, Bela
    Packer, Milton
    Prasad, Krishna
    Revkin, James
    Rosano, Giuseppe M. C.
    Somaratne, Ransi
    Stough, Wendy Gattis
    Voors, Adriaan A.
    Ruschitzka, Frank
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (05) : 482 - 489
  • [44] Effect of individualized communication skills training on physicians’ discussion of clinical trials in oncology: results from a randomized controlled trial
    Alexander Wuensch
    Tanja Goelz
    Gabriele Ihorst
    Darcey D. Terris
    Hartmut Bertz
    Juergen Bengel
    Michael Wirsching
    Kurt Fritzsche
    BMC Cancer, 17
  • [45] The use of ranolazine in non-anginal cardiovascular disorders: A review of current data and ongoing randomized clinical trials
    Mihos, Christos G.
    Krishna, Rama K.
    Kherada, Nisharahmed
    Larrauri-Reyes, Maiteder
    Tolentino, Alfonso
    Santana, Orlando
    PHARMACOLOGICAL RESEARCH, 2016, 103 : 49 - 55
  • [46] Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials
    Johansson, P. I.
    VOX SANGUINIS, 2008, 95 (01) : 1 - 7
  • [47] Hospital Resource Use After TAVR Clinical and Economic Lessons From Merging Large Databases
    Iung, Bernard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (10) : 1147 - 1148
  • [48] Subjective and objective outcomes in randomized clinical trials: definitions differed in methods publications and were often absent from trial reports
    Moustgaard, Helene
    Bello, Segun
    Miller, Franklin G.
    Hrobjartsson, Asbjorn
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2014, 67 (12) : 1327 - 1334
  • [49] Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?
    Hutchings, David Charles
    Anderson, Simon George
    Trafford, Andrew W.
    HEART, 2017, 103 (21) : 1745 - 1745
  • [50] Do arrhythmia patients improve survival by participating in randomized clinical trials? Observations from the cardiac arrhythmia suppression trial (CAST) and the Antiarrhythmics Versus Implantable Defibrillators trial (AVID)
    Hallstrom, A
    Friedman, L
    Denes, P
    Rizo-Patron, C
    Morris, M
    CONTROLLED CLINICAL TRIALS, 2003, 24 (03): : 341 - 352